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Abstract
Introduction: The	 lowest	 incidence	 of	 perinatal	 morbidity	 and	 mortality	 occurs	
around	39‐40	weeks.	Therefore,	some	have	advocated	induction	of	uncomplicated	
singleton	gestations	once	they	reach	full‐term.	The	aim	of	the	study	was	to	evaluate	
the	risk	of	cesarean	delivery,	and	any	maternal	and	perinatal	effects	of	a	policy	of	
induction	of	labor	in	women	with	full‐term	uncomplicated	singleton	gestations.
Material and methods: We	performed	an	electronic	search	from	inception	of	each	data‐
base	to	August	2018.	All	results	were	then	limited	to	randomized	trial.	No	restrictions	for	
language	or	geographic	location	were	applied.	Inclusion	criteria	were	randomized	clinical	
trials	of	asymptomatic	women	with	uncomplicated,	singleton	gestations	at	full‐term	(ie,	
between 39+0 and 40+6	weeks)	who	were	randomized	to	either	planned	 induction	of	
labor	or	control	(ie,	expectant	management).	Only	trials	on	asymptomatic	singleton	ges‐
tations	without	premature	rupture	of	membranes	or	any	other	indications	for	induction	
evaluating	the	effectiveness	of	planned	induction	of	labor	in	full‐term	singleton	gesta‐
tions	were	included.	The	primary	outcome	was	the	incidence	of	cesarean	delivery.
Results: Seven	randomized	clinical	trials,	including	7598	participants	were	analyzed.	
Three	studies	enrolled	only	women	with	favorable	cervix,	defined	as	a	Bishop	score	
of	 ≥5	 in	 nulliparous	women	 or	 ≥4	 in	multiparous	women.	One	 trial	 included	 only	
women	aged	35	years	or	older.	Women	randomized	to	the	planned	induction	of	labor,	
received scheduled induction usually at 39+0 to 39+6	weeks	of	 gestation,	whereas	
women	 in	 the	 control	 group	 received	 expectant	 management	 usually	 until	
41‐42	weeks	of	gestation,	or	earlier	if	medically	indicated.	Methods	of	induction	usu‐
ally	included	cervical	ripening,	with	either	misoprostol	or	Foley	catheter,	in	conjunc‐
tion	with	or	followed	by	oxytocin	for	women	with	unfavorable	cervix,	and	oxytocin	
and	artificial	rupture	of	membranes	for	those	with	favorable	cervix.	Five	trials	also	
used	artificial	rupture	of	membranes	as	a	method	for	induction.	Uncomplicated	full‐
term	singleton	gestations	 that	were	 randomized	 to	 receive	 induction	of	 labor	had	
similar	 incidence	 of	 cesarean	 delivery	 compared	 with	 controls	 (18.6%	 vs	 21.4%;	
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1  | INTRODUC TION
Several	 studies	have	shown	 that	 the	 lowest	 incidence	of	perinatal	
morbidity	and	mortality	occurs	at	around	39	weeks	of	gestation.1,2 
Perinatal	mortality	starts	to	 increase	with	 late‐term	and	post‐term	
pregnancies.3
Therefore,	 some	authors	have	advocated	 induction	of	 labor	of	
even	uncomplicated	singleton	pregnancies	once	they	reach	full‐term	
(39+0‐40+6	weeks).4‐8	 Opponents	 of	 such	 a	 policy	 have	 remarked	
that	 induction	has	often	been	associated	with	an	 increased	risk	of	
cesarean delivery.9‐12	 Randomized	 controlled	 trials	 of	 pregnancies	
with indications for induction have shown that induction is not asso‐
ciated	with	an	increased	risk	of	cesarean,	and	is	instead	associated	
with	maternal	and	perinatal	benefits.13‐15
The	aim	of	this	study	was	to	evaluate	the	risk	of	cesarean	deliv‐
ery	and	any	maternal	and	perinatal	effects	of	a	policy	for	induction	
of	labor	in	women	with	full‐term	uncomplicated	singleton	gestations.
2  | MATERIAL AND METHODS
2.1 | Search strategy
We	performed	electronic	research	in	Scopus,	ClinicalTrials.gov,	MEDLINE,	
the	PROSPERO	International	Prospective	Register	of	Systematic	Reviews,	
EMBASE,	and	the	Cochrane	Central	Register	of	Controlled	Trials	with	the	
use	of	the	following	key	words:	“induction,”	“cesarean	section,”	“expect‐
ant	management,”	and	“pregnancy”	from	inception	of	each	database	to	
August	2018.	All	results	were	then	limited	to	“clinical	trial.”	No	restric‐
tions	for	language	or	geographic	location	were	applied.
2.2 | Study selection and risk of bias
Inclusion	 criteria	 were	 randomized	 clinical	 trials	 of	 asymptomatic	
pregnant	 women	 with	 uncomplicated	 singleton	 gestations	 at	 full‐
term	 (ie,	 between	 39+0 and 40+6	weeks)	 who	 were	 randomized	 to	
either	 planned	 elective	 induction	 of	 labor	 or	 control	 (ie,	 expectant	
management).
Only	 trials	 on	 asymptomatic	 singleton	 gestations	without	 pre‐
mature	rupture	of	membranes	or	any	other	indications	for	induction	
evaluating	the	effectiveness	of	planned	“elective”	induction	of	labor	
in	 full‐term	 singleton	 gestations	 were	 included.	 Exclusion	 criteria	
included	 quasi‐randomized	 trials	 and	 trials	 in	women	with	 prema‐
ture	rupture	of	membranes,	or	with	indication	for	induction	(ie,	in‐
trauterine	 growth	 restriction,	 diabetes,	 gestational	 hypertension/
preeclampsia,	oligohydramnios,	fetal	macrosomia).
Inclusion criteria included different methods of induction, includ‐
ing	 amniotomy,	 balloon,	 oxytocin,	 and	 prostaglandins.	 Trials	 using	
methods of induction that are not currently considered the standard 
of	care,	such	as	laminaria	tent,	were	excluded	from	the	meta‐analysis.
The	 meta‐analysis	 was	 reported	 following	 the	 Preferred	
Reporting	Item	for	Systematic	Reviews	and	Meta‐analyses	(PRISMA)	
statement.16	Before	data	extraction,	the	review	was	registered	with	
the	 PROSPERO	 International	 Prospective	 Register	 of	 Systematic	
Reviews	(registration	no.:	CRD42018094876).
The	risk	of	bias	 in	each	 included	study	was	assessed	using	the	
criteria outlined in the Cochrane Handbook for Systematic Reviews of 
Interventions.17	Review	authors’	judgments	were	categorized	as	“low	
risk,”	“high	risk,”	or	“unclear	risk”	of	bias.
2.3 | Outcomes
All	analyses	were	performed	using	an	 intention‐to‐treat	approach,	
evaluating	women	according	to	the	treatment	group	to	which	they	
were randomly allocated in the original trials.
The	 primary	 outcome	 was	 the	 incidence	 of	 cesarean	 deliv‐
ery.	 Secondary	outcomes	were	 incidences	of	 spontaneous	 vaginal	
relative	risk	0.96,	95%	CI	0.78‐1.19).	Regarding	neonatal	outcomes,	induction	of	labor	
at full‐term was associated with a significantly lower rate of meconium‐stained amni‐
otic	fluid	(4.0%	vs	13.5%;	relative	risk	0.32,	95%	CI	0.18‐0.57),	and	lower	mean	birth‐
weight	 (mean	 difference	 −98.96	g,	 95%	CI	 −126.29	 to	 −71.63)	 compared	with	 the	
control	group.	There	were	no	between‐group	differences	in	other	adverse	neonatal	
outcomes.
Conclusions: Induction	of	labor	at	about	39	weeks	is	not	associated	with	increased	
risk	of	cesarean	delivery.
K E Y W O R D S
cesarean	delivery,	induction	of	labor,	operative	delivery,	oxytocin,	prostaglandin,	vaginal	
delivery
Key message
Induction of labor at full‐term is not associated with 
increased	risk	of	cesarean	delivery.
     |  3SACCONE Et Al.
delivery,	operative	vaginal	delivery	(either	forceps	or	vacuum),	cho‐
rioamnionitis,	mean	postpartum	blood	loss,	and	neonatal	outcomes	
including	meconium‐stained	amniotic	fluid	(MSAF),	Apgar	score	<7	
at 5 min, birthweight, admission to neonatal intensive care unit, and 
perinatal	death.
We	planned	to	assess	the	primary	outcome	in	subgroup	analyses	
of	women	with	favorable	cervix	(defined	as	a	Bishop	score	of	≥5	in	
nulliparous	women	or	≥4	in	multiparous	women),	with	unfavorable	
cervix,	of	nulliparous	women	only,	of	women	with	a	previous	cesar‐
ean	section,	and	of	trials	published	after	2010.
2.4 | Data analysis
The	 data	 analysis	 was	 completed	 using	 Review ManageR	 5.3	 (The	
Nordic	Cochrane	Centre	2014,	Copenhagen,	Denmark).
The	summary	measures	were	reported	as	summary	relative	risk	
(RR)	or	as	summary	mean	difference	with	95%	confidence	intervals	
(95%	CI)	using	the	random	effects	model	of	Der	Simonian	and	Laird.	
I‐squared	(Higgins	I2)	>0%	was	used	to	identify	heterogeneity	and	a	
P	value	<.05	was	considered	statistically	significant.
3  | RESULTS
3.1 | Study selection and study characteristics
We initially identified 18 trials evaluating the effectiveness of in‐
duction	 of	 labor	 in	women	with	 full‐term	 pregnancies.4‐8,13‐15,18‐27 
Eleven	 studies	 were	 excluded.13‐15,18,25	 Seven	 randomized	 clinical	
trials,	 including	7598	participants,	which	met	 the	 inclusion	criteria	
for	 this	 meta‐analysis,	 were	 analyzed.4‐8,26,27	 Figure	1	 shows	 the	
flow	diagram	(PRISMA	template)	of	information	through	the	differ‐
ent	phases	of	 the	 review.	Two	authors	provided	unpublished	data	
from their trials.7,8
The	overall	 risk	 of	 bias	was	 judged	 as	 low.	Most	 studies	 had	
a	 low	risk	of	bias	 in	selective	reporting	and	 incomplete	outcome	
data	according	to	the	Cochrane	Collaboration	tool.	No	study	was	
double blind because this was deemed difficult methodologically 
given	the	intervention	(Figure	2).	Statistical	heterogeneity	within	
the	trials	ranged	from	low	to	high	with	no	inconsistency	(I2	=	0%)	
for some of the secondary outcomes, and I2	=	38%	for	the	primary	
outcome.
The	 characteristics	 of	 the	7	 included	 trials	 are	 summarized	 in	
Table	1.	Of	the	7598	women,	3807	(50%)	were	randomized	to	the	
induction	group,	and	3791	(50%)	to	control.	All	studies	enrolled	only	
uncomplicated	full‐term	vertex	singleton	gestations.	Three	studies	
enrolled	only	women	with	a	favorable	cervix,	defined	as	a	Bishop	
score	 of	 ≥5	 in	 nulliparous	 women	 or	 ≥4	 in	 multiparous	 women.	
Walker	 et	al	 included	 only	 women	 aged	 ≥35	years.	 Women	 ran‐
domized	 in	the	planned	 induction	of	 labor,	received	scheduled	 in‐
duction usually at 39+0 to 39+6	weeks	of	gestation,	whereas	women	
in	the	control	group	received	expectant	management	usually	until	
41‐42	weeks	 of	 gestation,	 or	 earlier	 if	 medically	 indicated.25,26 
Methods	of	induction	usually	included	cervical	ripening,	with	either	
misoprostol	or	Foley	catheter,	 in	conjunction	with	or	 followed	by	
oxytocin	for	women	with	unfavorable	cervix	(Bishop	score	<5),	and	
Oxytocin	alone	for	 those	with	favorable	cervix	 (Bishop	score	≥5).	
Five	trials	also	used	artificial	rupture	of	membranes	as	method	for	
induction.
3.2 | Synthesis of results
Uncomplicated	 full‐term	 singleton	 gestations	who	 received	 induc‐
tion	 of	 labor	 had	 similar	 incidence	 of	 cesarean	 delivery	 compared	
with	controls	(18.6%	vs	21.4%;	RR	0.96,	95%	CI	0.78‐1.19)	(Figure	3).	
Regarding neonatal outcomes, induction was associated with a 
significantly	 lower	 rate	of	MSAF	 (4.0%	vs	13.5%;	RR	0.32,	95%	CI	
0.18‐0.57)	 (Figure	4),	 and	 significantly	 lower	 mean	 birthweight	
(mean	 difference	 −98.96	g,	 95%	 CI	 −126.29	 to	 −71.63)	 compared	
with	the	control	group.	There	were	no	differences	in	other	adverse	
neonatal	outcomes	(Table	2).
Table	3	shows	the	results	for	primary	outcome	in	the	subgroup	
analyses. We found no differences in the rate of cesarean delivery in 
women	with	favorable	or	unfavorable	cervix	and	nulliparous	women,	
and	in	trials	published	after	2010	(Table	3).	No	study	stratified	data	
by	previous	cesarean	section.
F I G U R E  1  Flow	diagram	of	studies	identified	in	the	systematic	
review
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4  | DISCUSSION
This	meta‐analysis	of	pooled	data	of	the	7	randomized	controlled	trials	
(RCTs)	evaluating	full‐term	uncomplicated	vertex	singleton	gestations	
showed	that	scheduled	 induction	of	 labor	at	about	39	weeks	 is	not	
associated	with	an	increased	risk	of	cesarean	delivery	compared	with	
controls	expectantly	managed	at	least	until	≥41	weeks.	Furthermore,	
induction of labor was associated with a significantly lower rate of 
MSAF.	MSAF	 is	 associated	 with	 an	 increased	 risk	 of	 adverse	 fetal	
outcomes	 including	meconium	 aspiration	 syndrome,	 cerebral	 palsy,	
seizure,	and	pulmonary	disease.28‐32	Meconium	aspiration	syndrome	
occurs	in	5%	of	the	cases	of	MSAF	and	>4%	of	infants	with	meconium	
aspiration	syndrome	die,	accounting	for	2%	of	perinatal	deaths.31,32
Although	 induction	 was	 associated	 with	 lower	 birthweight,	 a	
mean	difference	of	about	100	g	at	full‐term	is	probably	not	clinically	
significant, and we found no differences in adverse neonatal out‐
comes,	including	Apgar	score	<7	at	5	min,	and	admission	to	neonatal	
intensive	care	unit	between	intervention	and	control	groups.	There	
were	 3	 fewer	 perinatal	 deaths	 in	 the	 induction	 vs	 control	 group	
(Table	2),	which	equates	to	about	one	fewer	perinatal	deaths	every	
1000	births	if	a	woman	is	induced	at	39	weeks	vs	expectant	manage‐
ment, but this difference was not significant, and our study was not 
powered	for	this	outcome.
Other meta‐analyses have addressed induction of labor and 
cesarean delivery.33‐38	 Two	 reviews33,34 included women with in‐
dications for induction, such as intrauterine growth restriction, 
F I G U R E  2  Assessment	of	risk	of	bias.	A,	Summary	of	risk	of	bias	for	each	trial;	plus	sign:	low	risk	of	bias;	minus	sign:	high	risk	of	bias;	
question	mark:	unclear	risk	of	bias.	B,	Risk	of	bias	graph	about	each	risk	of	bias	item	presented	as	percentages	across	all	included	studies	
[Color figure can be viewed at wileyonlinelibrary.com]
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hypertensive	complications,	or	gestation	≥41	weeks.	Both	showed	
not only no increase in cesarean delivery, but a significant decrease 
in	 the	 incidence	 of	 cesarean	 delivery.	 Saccone	 and	 Berghella35 
showed	that	induction	of	labor	at	full‐term	in	women	with	uncompli‐
cated	singleton	pregnancies	was	not	associated	with	increased	risk	
of	 cesarean	delivery.	However,	 they	 included	only	 trials	published	
before	 2014,	 and	 therefore	 fewer	 trials	 and	 fewer	 participants.	
Sotiriadis	et	al	 recently	published	a	meta‐analysis	on	 the	effect	of	
induction	of	 labor	at	39	weeks	compared	with	expectant	manage‐
ment	on	 the	 risk	of	 cesarean	delivery,	 and	on	maternal	death	and	
neonatal intensive care admission.36	 This	 meta‐analysis,	 including	
5	studies	(n	=	7261),	is	concordant	with	our	findings	from	7	studies	
(n	=	7598)	showing	that	planned	induction	of	labor	in	uncomplicated	
singleton	pregnancy	at	39	weeks	of	gestation	may	reduce	the	need	
for	cesarean	delivery,	as	well	as	the	risk	of	hypertensive	disease	of	
pregnancy	and	the	need	for	neonatal	respiratory	support.36	Notably	
the	 meta‐analysis	 by	 Sotiriadis	 et	al	 excluded	 3	 RCTs6‐8 each of 
which	included	women	only	with	a	favorable	or	unfavorable	cervix.	
For	example	the	Miller	et	al	study8	only	included	women	with	Bishop	
score	≤5	whereas	Tyllerskar	et	al6	and	Nielsen	et	al7 only included 
women	with	a	favorable	cervical	examination.	The	addition	of	these	
3 studies6‐8 causes the cesarean delivery rate to be non‐significant 
in this study.
Limitations	of	our	study	are	inherent	to	the	limitations	of	the	in‐
cluded	RCTs.	Only	2	of	the	included	RCTs	had	cesarean	delivery	as	
primary	outcome.	No	long‐term	outcomes	were	reported	in	any	of	
the	trials.	The	vast	majority	of	the	included	participants	came	from	
one	large	RCT,	which	therefore	drives	the	results.
Induction	of	labor	can	be	used	to	intervene	in	a	pregnancy	when	
the	risks	of	continuing	the	pregnancy	outweigh	those	of	intervention.	
However,	induction	was	once	widely	believed	to	increased	the	risk	
of cesarean delivery.12,38 Several studies also showed higher rates of 
cesarean delivery in women who underwent induction of labor com‐
pared	with	those	who	underwent	spontaneous	labor.38 However, at 
any	given	point	in	a	pregnancy,	the	decision	is	not	between	induction	
of	labor	and	spontaneous	labor,	but	between	induction	and	expect‐
ant	management,	which	 yields	 a	 pregnancy	 of	 greater	 gestational	
age	and	which	may	not	lead	to	spontaneous	labor.39
Recently,	the	ARRIVE	trial	concluded	that	 induction	of	 labor	at	
39	weeks	of	gestation	in	low‐risk	nulliparous	women	did	not	result	
in	a	significantly	lower	frequency	of	adverse	perinatal	outcome,	but	
did result in lower frequency of cesarean delivery.27	The	American	
College	 of	 Obstetricians	 and	 Gynecologists	 and	 the	 Society	 for	
Maternal‐Fetal	Medicine	released	a	statement	in	response	to	the	re‐
sults	of	the	ARRIVE	trial.40	Given	the	benefit	in	terms	of	decreased	
risk	 of	 cesarean	 delivery,	 the	 American	 College	 of	 Obstetricians	
and	Gynecologists	and	the	Society	for	Maternal‐Fetal	Medicine	de‐
termined	that	 it	 is	 reasonable	 for	obstetric	care	providers	 to	offer	
an	 induction	of	 labor	 at	39	weeks	 in	well‐dated	 low‐risk	 singleton	
pregnancies.
This	meta‐analysis,	including	data	from	the	ARRIVE	trial,	showed	
that	induction	of	labor	in	asymptomatic	and	uncomplicated	singleton	
F I G U R E  3  Forest	plot	for	the	risk	of	cesarean	delivery	[Color	figure	can	be	viewed	at	wileyonlinelibrary.com]
F I G U R E  4  Forest	plot	for	the	risk	of	meconium‐stained	amniotic	fluid	[Color	figure	can	be	viewed	at	wileyonlinelibrary.com]
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gestations	at	full‐term	(390‐406	weeks)	is	not	associated	with	an	in‐
creased	risk	of	cesarean	delivery,	but	is	in	fact	associated	with	a	sig‐
nificantly	lower	risk	of	MSAF.
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